Evaluation of the Predictive Value of CHA₂DS₂-VASc Score for In-Stent Restenosis

Area of Science:

• Cardiology
• Interventional Cardiology
• Biostatistics

Background:

• The CHA2DS2-VASc score assesses thromboembolic risk in atrial fibrillation (AF).
• Its utility in predicting in-stent restenosis (ISR) after coronary stent implantation is not established.
• Understanding predictors of ISR is crucial for improving cardiovascular outcomes.

Purpose of the Study:

• To evaluate the predictive value of the CHA2DS2-VASc score for in-stent restenosis (ISR) in patients who underwent successful bare-metal stent implantation.
• To determine if the CHA2DS2-VASc score can serve as a simple tool for identifying patients at higher risk of ISR.

Main Methods:

• Analysis of 1350 patients undergoing coronary angiography and bare-metal stent implantation.
• Calculation of CHA2DS2-VASc scores prior to percutaneous coronary intervention.
• Comparison of CHA2DS2-VASc scores between patients with and without ISR using multivariate logistic regression.

Main Results:

• A cohort of 700 patients was analyzed, with 265 (37.8%) experiencing ISR.
• Patients with ISR had a significantly higher mean CHA2DS2-VASc score (3.7) compared to those without ISR (2.1) (P < .001).
• Multivariate analysis identified diabetes, hyperlipidemia, smoking, stent length, and CHA2DS2-VASc score as independent predictors of ISR.

Conclusions:

• The CHA2DS2-VASc score demonstrates potential as a novel and straightforward predictor of in-stent restenosis (ISR).
• This score could aid clinicians in risk-stratifying patients undergoing coronary stent implantation for ISR development.
• Further research may validate the CHA2DS2-VASc score for ISR prediction in diverse patient populations.